Drreddys Laboratories | RDY - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
ANI Pharmaceuticals USD 40.22M 8.74M 2026-03
Aurora Cannabis CAD 11.41M 12.99M 2026-03
Bayer EUR 321M 2.67B 2026-06
Canopy Growth CAD -157.96M 95.71M 2026-03
Cipla INR 10.82B 3.33B 2026-06
Corcept Therapeutics USD -44.72M 54.62M 2026-03
Drreddys Laboratories INR 2B 13.43B 2026-03
GlaxoSmithKline GBP 2.68B 532M 2026-06
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Lonza CHF 624M 197M 2024-12
Novartis USD 4.27B 430M 2026-06
Pacira USD 5M 4.43M 2026-03
Phibro Animal Health USD 38.62M 1.26M 2025-12
Prestige Brands USD 64.77M 2.96M 2026-03
Richter Gedeon HUF 78.56B 32.66B 2024-12
Sun Pharmaceuticals INR 35.51B 6.76B 2026-03
Supernus Pharmaceuticals USD -57.65M 51.7M 2026-06
Teva Pharmaceutical Industries USD -455M 1.21B 2026-06